Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
13.50
-0.31 (-2.24%)
At close: Jul 20, 2026, 4:00 PM EDT
13.60
+0.10 (0.74%)
After-hours: Jul 20, 2026, 7:45 PM EDT
Summit Therapeutics Market Cap
Summit Therapeutics has a market cap or net worth of $10.48 billion as of July 20, 2026. Its market cap has decreased by -46.15% in one year.
Market Cap
10.48B
Enterprise Value
10.12B
1-Year Change
-46.15%
Ranking
Category
Stock Price
$13.50
ChartMarket Cap Chart
Since March 5, 2015, Summit Therapeutics's market cap has increased from $119.00M to $10.48B, an increase of 8,705.21%. That is a compound annual growth rate of 48.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 10.48B | -19.52% |
| Dec 31, 2025 | 13.02B | -1.06% |
| Dec 31, 2024 | 13.16B | 619.43% |
| Dec 29, 2023 | 1.83B | 113.79% |
| Dec 30, 2022 | 855.60M | 225.45% |
| Dec 31, 2021 | 262.90M | -32.00% |
| Dec 31, 2020 | 386.60M | 653.61% |
| Dec 31, 2019 | 51.30M | 203.55% |
| Dec 31, 2018 | 16.90M | -87.66% |
| Dec 29, 2017 | 137.00M | 30.60% |
| Dec 30, 2016 | 104.90M | -21.83% |
| Dec 31, 2015 | 134.20M | 12.77% |
| Mar 5, 2015 | 119.00M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Axsome Therapeutics | 11.84B |
| ABIVAX Société Anonyme | 11.76B |
| BioMarin Pharmaceutical | 11.52B |
| Bio-Techne | 11.24B |
| Cytokinetics | 10.89B |
| Arrowhead Pharmaceuticals | 10.47B |
| Krystal Biotech | 10.46B |
| Apogee Therapeutics | 10.04B |